NCT05540964 An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy Status UNKNOWN Phase N/A
NCT05540652 Developing an Online Mindfulness-based Intervention to Reduce Minority Stress and HIV Risk Among Young Adult MSM Status COMPLETED Phase NA
NCT05540171 An Educational Intervention Program to Improve the Oral Health of HIV-Positive Children in Kano, Nigeria. Status COMPLETED Phase NA
NCT05529342 Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product ,AGT103-T Status ENROLLING_BY_INVITATION Phase N/A
NCT05525533 Supporting Young Women's Reproductive Health by Harnessing Prosociality Among Drug Shopkeepers Status TERMINATED Phase NA
NCT05525156 The Effect of Aspirin on HIV Disease Progression Among HIV- Infected Individuals Initiating Anti- Retroviral Therapy Status SUSPENDED Phase PHASE2
NCT05516069 Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction. Status RECRUITING Phase NA
NCT05514899 Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV Status RECRUITING Phase PHASE2
NCT05504954 A Comprehensive HIV Prevention Package for South African Adolescent Girls and Young Women: IMARA SA Status COMPLETED Phase NA
NCT05503173 Telehealth for Pain and Unhealthy Drinking Among PLWH Status ACTIVE_NOT_RECRUITING Phase NA
NCT05489406 Relative Bioavailability Study to Investigate a Potential Interaction Between DTG DT and F/TAF TOS. Status COMPLETED Phase PHASE1
NCT05484895 Mobile Health Intervention to Increase HIV Testing and Linkage to Care Status COMPLETED Phase NA
NCT05483686 Improving HIV Outcomes Among African American Transgender Women Status COMPLETED Phase NA
NCT05470491 Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ... Status RECRUITING Phase PHASE1/PHASE2
NCT05470400 A Clinical Trial to Evaluate Safety, Tolerability, and Immunogenicity of Adjuvanted HIV-1 Fusion Peptide Conjugate Vaccine Alone or in Prime-Boost Regimens With Adjuvanted HIV-1 Envelope Trimer 4571 and HIV-1 Trimer 6931 Vaccines in Healthy Adults Status TERMINATED Phase PHASE1